Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders

Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders

Bibliographic Details
Main Authors: David A. Isenberg, Amy H. Kao, Aida Aydemir, Joan T. Merrill
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Immunology
Subjects:
BAFF
APRIL
TACI
B cell
monoclonal antibody
multiple sclerosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.592639/full
id doaj-53211577c68242d08527bf89d4a18f2a
record_format Article
spelling doaj-53211577c68242d08527bf89d4a18f2a2020-11-25T04:00:20ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-11-011110.3389/fimmu.2020.592639592639Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated DisordersDavid A. Isenberg0Amy H. Kao1Aida Aydemir2Joan T. Merrill3Centre for Rheumatology/Division of Medicine, University College London, London, United KingdomGlobal Clinical Development, EMD Serono Research and Development Institute, Inc., Billerica, MA, United States (an affiliate of Merck KGaA, Darmstadt, GermanyGlobal Biostatistics, EMD Serono Research and Development Institute, Inc., Billerica, MA, United States (an affiliate of Merck KGaA, Darmstadt, GermanyArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2020.592639/fullBAFFAPRILTACIB cellmonoclonal antibodymultiple sclerosis
collection DOAJ
language English
format Article
sources DOAJ
author David A. Isenberg
Amy H. Kao
Aida Aydemir
Joan T. Merrill
spellingShingle David A. Isenberg
Amy H. Kao
Aida Aydemir
Joan T. Merrill
Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
Frontiers in Immunology
BAFF
APRIL
TACI
B cell
monoclonal antibody
multiple sclerosis
author_facet David A. Isenberg
Amy H. Kao
Aida Aydemir
Joan T. Merrill
author_sort David A. Isenberg
title Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
title_short Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
title_full Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
title_fullStr Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
title_full_unstemmed Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
title_sort commentary: systematic review of safety and efficacy of atacicept in treating immune-mediated disorders
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-11-01
topic BAFF
APRIL
TACI
B cell
monoclonal antibody
multiple sclerosis
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.592639/full
work_keys_str_mv AT davidaisenberg commentarysystematicreviewofsafetyandefficacyofataciceptintreatingimmunemediateddisorders
AT amyhkao commentarysystematicreviewofsafetyandefficacyofataciceptintreatingimmunemediateddisorders
AT aidaaydemir commentarysystematicreviewofsafetyandefficacyofataciceptintreatingimmunemediateddisorders
AT joantmerrill commentarysystematicreviewofsafetyandefficacyofataciceptintreatingimmunemediateddisorders
_version_ 1724451247962980352

Similar Items